Skip to main content Accessibility help
×
Home

On the Discounting of Gained life-Years in Cost-Effectiveness Analysis

  • Magnus Johannesson (a1)

Abstract

A controversial issue in cost-effectiveness analysis is the discounting of gained life-years. What has not been realized, however, is that the different methods used for discounting this measurement provide fundamentally different results. The method used is seldom explicitly stated. In the present article the four main methods for the discounting of gained life-years are reviewed and compared. The conclusion is that if we wish to continue comparing results, researchers must employ the same methodology.

Copyright

References

Hide All
1.Christiansen, T., Pedersen, K. L., Harvald, B., et al. A health economic investigation of the effect of treatment for hypertension. Odense University: Research report No. 6, 1987.
2.Christiansen, T., Pedersen, K. L., Harvald, B., et al. An investigation of the effect of regional variation in the treatment of hypertension, Social Science and Medicine, 1989, 28, 131–39.
3.Drummond, M. F., Stoddard, G. L., & Torrance, G. W.Methods for the economic evaluation of health care programmes. Oxford: Oxford Medical Publications, 1987.
4.Jönsson, B., Horisberger, B., Bruguera, M., & Matter, L.Cost-benefit analysis of hepatitis-B vaccination: A computerized model for Spain. International Journal of Technology Assessment in Health Care, 1991, 7, 379402.
5.Keeler, E. B., & Cretin, S.Discounting of life-saving and other nonmonetary effects, Management Science, 1983, 29, 300306.
6.Kinosian, B. P., & Eisenberg, J. M.Cutting into cholesterol: Cost-effective alternatives for treating hypercholesterolemia. Journal of the American Medical Association, 1988, 259, 2249–54.
7.Rosen, S.The value of changes in life expectancy. Journal of Risk and Uncertainty, 1988, 1, 285304.
8.Statistics Sweden. Statistical abstract of Sweden 1988, Stockholm: Norstedts, 1987.
9.Waaler, H., Helgeland, A., Hjort, P., et al. Hoyt blodtrykk: Behandlingsprogram, utbytte, kostnader. Norges allmenvitenskapelige forskningsrads gruppe for helsetjensteforskning, Rapport Nr. 5, 1978.
10.Weinstein, M. C., & Stason, W. B.Hypertension: A policy perspective. Cambridge, MA: Harvard University Press, 1976.
11.Weinstein, M. C., & Stason, W. B.Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine, 1977, 296, 732–39.
12.Weinstein, M. C., & Stason, W. B.Cost-effectiveness of interventions to prevent or treat coronary heart disease. Annual Review of Public Health, 1985, 6, 4163.

Related content

Powered by UNSILO

On the Discounting of Gained life-Years in Cost-Effectiveness Analysis

  • Magnus Johannesson (a1)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.